Correlation Between Avenue Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on Avenue Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and Bio Path.
Diversification Opportunities for Avenue Therapeutics and Bio Path
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Avenue and Bio is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between Avenue Therapeutics and Bio Path
Given the investment horizon of 90 days Avenue Therapeutics is expected to generate 0.58 times more return on investment than Bio Path. However, Avenue Therapeutics is 1.73 times less risky than Bio Path. It trades about -0.05 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.16 per unit of risk. If you would invest 195.00 in Avenue Therapeutics on September 14, 2024 and sell it today you would lose (9.00) from holding Avenue Therapeutics or give up 4.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avenue Therapeutics vs. Bio Path Holdings
Performance |
| Timeline |
| Avenue Therapeutics |
| Bio Path Holdings |
Avenue Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avenue Therapeutics and Bio Path
The main advantage of trading using opposite Avenue Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Neurobo Pharmaceuticals | Avenue Therapeutics vs. Virax Biolabs Group |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |